Pain drawings in evaluating treatment benefit of Botulin toxin in masticatory muscle pain [0.03%]
肉毒杆菌治疗咀嚼肌痛疗效评估中的疼痛描图法
Alina Valli,Victoria Sitnikova,Pentti Kemppainen et al.
Alina Valli et al.
Objectives: Studies on the use of botulinum toxin A (BoNT-A) in TMD-related myalgia suggest that some patients benefit from the injections. The aim of this study was to assess which patient group, regarding pain sites and...
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee' [0.03%]
系统性硬化症局部治疗数字溃疡建议：世界硬化症基金会(WSF)“特别工作组”报告
Corrado Campochiaro,Yossra A Suliman,Dilia Giuggioli et al.
Corrado Campochiaro et al.
Among topical non-surgical options, botulin toxin can be conditionally recommended for refractory and/or severe DUs.
Improving Spasticity by Using Botulin Toxin: An Overview Focusing on Combined Approaches [0.03%]
肉毒杆菌改善肌张力异常：综述结合多种方法的角度分析
Loredana Raciti,Gianfranco Raciti,Antonio Ammendolia et al.
Loredana Raciti et al.
The botulin toxin type A (BoNT-A) injection has been effectively used to improve different types of spasticity. However, when BoNT-A is not sufficient, a combination of nonpharmacological approaches could be attempted.
The Effectiveness of Combining Botulinum Toxin Type A and Therapeutic Exercise in Treating Spasticity in a Patient with Complicated Stiff-Person Syndrome: A Case Report [0.03%]
肉毒杆菌A型联合康复训练治疗复杂性僵人综合征所致痉挛一例报告
Riccardo Marvulli,Maria Vittoria Raele,Mariagrazia Riccardi et al.
Riccardo Marvulli et al.
All the assessments were conducted at the first evaluation (T0), soon after the combined treatment with botulin toxin and therapeutic exercise (T1), three months (T2), six months (T3), and eight months after the botulinum toxin injection (T4).
Botulinum Toxin Type A in the Treatment of Raynaud's Syndrome: A Case Report [0.03%]
A型肉毒杆菌毒素治疗雷诺病一例报告
Plamen Penchev,Valentin Dobrev,Petar-Preslav Petrov et al.
Plamen Penchev et al.
The application of botulin toxin is commonly indicated in several medical conditions including focal dystonia, spasticity with or without contractures, paraparesis in children with cerebral palsy, multiple sclerosis, brain injuries, involuntary muscle hyperactivity of a non-dystonic nature, pain management...We present a clinical case of a 70-year-old female patient with Raynaud's syndrome in which we have placed 70E distributed to both hands botulin toxin type A.
Case Reports
Cureus. 2024 Mar 31;16(3):e57327. DOI:10.7759/cureus.57327 2024
Distal renal tubular acidosis as a rare complication of vesicoureteral reflux in children: a case report and literature review [0.03%]
儿童输尿管膀胱反流罕见并发症远端肾小管酸中毒的病例报告和文献回顾
Emre Leventoğlu
Emre Leventoğlu
She had a history of subureteral injection of various agents and botulin toxin injection into the bladder. Her voiding cystourethrogram revealed grade 5 VUR in the left kidney, tortuosity in the left ureter, and the bladder had a dome-like appearance and was trabeculated.
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System [0.03%]
肉毒杆菌毒素注射美容程序相关的皮肤不良反应：来自欧洲自发呈报系统的数据
Maria Maddalena Nicoletti,Antonietta Anatriello,Valerio Liguori et al.
Maria Maddalena Nicoletti et al.
Having a long-lasting effect, Botulinum toxin type A (BTA) is one of the most botulin toxin products used.
Identifying treatment non-responders based on pre-treatment gait characteristics - A machine learning approach [0.03%]
基于治疗前步态特征识别治疗无反应者——一种机器学习方法
Rosa M S Visscher,Julia Murer,Fatemeh Fahimi et al.
Rosa M S Visscher et al.
Methods: Observational data of 119 patients with movement disorders were retrospectively extracted from a local clinical database, comprising sagittal joint angles and spatiotemporal parameters, derived from motion capture data pre- and post-treatment (physiotherapy, orthosis, botulin...toxin injections, or surgery).
Guided Superficial Enhanced Fluid Fat Injection (SEFFI) Procedures for Facial Rejuvenation: An Italian Multicenter Retrospective Case Report [0.03%]
意大利多中心回顾性案例报告引导的浅表增强液体脂肪移植（SEFFI）面部年轻化程序
Alessandro Gennai,Monica Baldessin,Fabrizio Melfa et al.
Alessandro Gennai et al.
In about one-tenth of the patients, guided SEFFI was combined with a botulin toxin treatment or hyaluronic acid filling. Other procedures were used more rarely.
Preliminary Findings of the Efficacy of Botulinum Toxin in Temporomandibular Disorders: Uncontrolled Pilot Study [0.03%]
肉毒杆菌毒素治疗颞下颌关节紊乱病的初步疗效观察：无对照的研究报告
José A Blanco-Rueda,Antonio López-Valverde,Antonio Márquez-Vera et al.
José A Blanco-Rueda et al.
Keywords: botox; botulin toxin therapy; masticatory dysfunction syndrome; pilot study; temporomandibular disorders.
耗时 0.08976 秒，为您在
48206918
条记录里面共找到 152 篇文章 [XML]